Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Capital Expenditures (2016 - 2025)

Mesa Laboratories' Capital Expenditures history spans 16 years, with the latest figure at $732000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 9.96% year-over-year to $732000.0; the TTM value through Dec 2025 reached $3.6 million, down 10.85%, while the annual FY2025 figure was $4.2 million, 65.52% up from the prior year.
  • Capital Expenditures for Q4 2025 was $732000.0 at Mesa Laboratories, down from $1.1 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $2.1 million in Q4 2021 and bottomed at $225000.0 in Q2 2022.
  • The 5-year median for Capital Expenditures is $914500.0 (2021), against an average of $983150.0.
  • The largest annual shift saw Capital Expenditures soared 733.6% in 2021 before it plummeted 65.54% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $2.1 million in 2021, then dropped by 19.67% to $1.7 million in 2022, then crashed by 31.8% to $1.1 million in 2023, then decreased by 27.93% to $813000.0 in 2024, then fell by 9.96% to $732000.0 in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Capital Expenditures are $732000.0 (Q4 2025), $1.1 million (Q3 2025), and $1.0 million (Q2 2025).